Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

NMNAT2 Antikörper (Intracellular)

Der Kaninchen Polyklonal anti-NMNAT2 Antikörper wird verwendet zum Nachweis von NMNAT2 in Proben von Human, Maus und Ratte. Er wurde validiert für WB und IHC.
Produktnummer ABIN7885201
1.466,46 €
Zzgl. Versandkosten 20,00 € und MwSt
200 μL
Lieferung nach: Deutschland
Lieferung in 8 bis 9 Werktagen

Kurzübersicht für NMNAT2 Antikörper (Intracellular) (ABIN7885201)

Target

Alle NMNAT2 Antikörper anzeigen
NMNAT2 (Nicotinamide Nucleotide Adenylyltransferase 2 (NMNAT2))

Reaktivität

Human, Maus, Ratte

Wirt

  • 16
  • 8
  • 1
Kaninchen

Klonalität

  • 18
  • 7
Polyklonal

Konjugat

  • 13
  • 4
  • 2
  • 2
  • 2
  • 2
Dieser NMNAT2 Antikörper ist unkonjugiert

Applikation

  • 19
  • 18
  • 5
  • 4
  • 3
Western Blotting (WB), Immunohistochemistry (IHC)

Güteklasse

Carrier-free
  • Bindungsspezifität

    • 6
    • 5
    • 5
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 131-146, Intracellular

    Verwendungszweck

    A Rabbit polyclonal antibody to NMNAT2.

    Homologie

    Rat - identical,Human12,16 identical.

    Aufreinigung

    Affinity purified on immobilized antigen.

    Immunogen

    (C)HENTQPIYQNSNVPTK, corresponding to amino acid residues 131 - 146 of mouse NMNAT2

    Isotyp

    IgG
  • Applikationshinweise

    The optimal concentration should be determined by the user

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    0.2 mL double distilled water (DDW)

    Konzentration

    1 mg/mL

    Buffer

    PBS pH 7.4

    Konservierungsmittel

    Without preservative

    Lagerung

    -20 °C

    Informationen zur Lagerung

    The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C
  • Target

    NMNAT2 (Nicotinamide Nucleotide Adenylyltransferase 2 (NMNAT2))

    Andere Bezeichnung

    Nicotinamide mononucleotide adenylyltransferase 2

    Hintergrund

    Synonyms: Nicotinamide mononucleotide adenylyltransferase 2, Nicotinamide Nucleotide Adenylyltransferase 2, Nicotinamide/Nicotinic Acid Mononucleotide Adenylyltransferase 2, NMN adenylyltransferase 2

    Description: Nicotinamide mononucleotide adenylyltransferase 2, also referred to as NMNAT2, belongs to the NMNAT family of enzymes responsible for NAD+ biosynthesis. This family catalyzes the final step in NAD+ production, converting nicotinamide mononucleotide (NMN) and ATP to NAD+. NMNAT2 is predominantly localized in the cytoplasm and Golgi apparatus, distinguishing it from NMNAT1 (nuclear) and NMNAT3 (mitochondrial) counterparts. Structurally, NMNATs share conserved ATP-binding motifs crucial for their enzymatic functions1-3. In addition to its enzymatic role, NMNAT2 also functions as a chaperone, mitigating protein aggregation under proteotoxic stress. Its enzymatic and chaperone activities are recruited in a context-dependent manner, protecting against excitotoxicity and proteotoxic stress, respectively. This dual functionality highlights its significance in cellular stress responses5. NMNAT2 plays a critical role in cellular energy metabolism by maintaining NAD+ pools, essential for redox reactions and the activity of sirtuins and PARPs, key regulators of gene expression and stress responses. NMNAT2's cytoplasmic localization facilitates its involvement in glucose metabolism and the regulation of compartmentalized NAD+ availability, which is crucial for processes like adipogenesis4. In neurons, NMNAT2 contributes to axonal protection and integrity by modulating NAD+-dependent repair pathways, highlighting its neuroprotective roles5. NMNAT2 protein levels are tightly regulated post-transcriptionally, with a short half-life necessitating constant replenishment, and its expression is induced by glucose metabolism3. Tissue-specific expression studies reveal that NMNAT2 is highly abundant in the brain, heart, and skeletal muscle, reflecting its importance in energy-demanding tissues. At the cellular level, its expression is notable in neurons, cardiomyocytes, and other metabolically active cells3-5. Clinically, reduced NMNAT2 levels have been observed in neurodegenerative diseases like Alzheimer's, where its decline precedes neurodegeneration, underscoring its potential as a therapeutic target. Dysregulated NMNAT2 activity has also been implicated in cardiac hypertrophy, demonstrating its broad relevance in disease pathophysiology1,3,5.

    Gen-ID

    226518
Sie sind hier:
Chat with us!